Adrian Kielhorn

Adrian Kielhorn is a seasoned professional with extensive experience in health economics and market access within the pharmaceutical industry. Currently serving as Senior Director of Global HEOR Neurology at Alexion Pharmaceuticals, Inc., since February 2019, Adrian leads a dedicated team focused on Neurology therapeutic areas. Prior roles include Senior Director of Neurology, Global Market Access at EMD Serono, Inc., where Adrian shaped pricing and market access strategies for multiple pipeline products, and Director of Global Health Economics at Amgen. Earlier experiences include key positions at Roche Pharma AG and F. Hoffmann - La Roche, where Adrian contributed to strategic economic leadership and market access initiatives. Adrian began the career at Eli Lilly as Health Outcomes Team Leader and held a managerial role at GSK. Adrian holds a German equivalent of an MBA in Economics from the University of Hanover and a BA in Economics and Business Administration from Leibniz Universität Hannover.